Cargando…

Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Wong, Andy O.-T., Gurung, Bimal, Wong, Wing Sum, Mak, Suet Yee, Tse, Wan Wai, Li, Chloe M., Lieu, Deborah K., Costa, Kevin D., Li, Ronald A., Hajjar, Roger J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483631/ http://dx.doi.org/10.1016/j.vascn.2021.107036

Ejemplares similares

Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues
por: Wong, Andy On-Tik, et al.
Publicado: (2021)

Correlation between frataxin expression and contractility revealed by in vitro Friedreich’s ataxia cardiac tissue models engineered from human pluripotent stem cells
por: Wong, Andy On-Tik, et al.
Publicado: (2019)

Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases
por: Zhu, Xiaojia, et al.
Publicado: (2022)

Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
por: Wu, Qin, et al.
Publicado: (2023)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic
por: Dauner, Daniel G., et al.
Publicado: (2021)

Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration
por: Li, Wener, et al.
Publicado: (2022)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
por: Derendorf, Hartmut
Publicado: (2020)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Arrhythmogenic Mechanisms in Hypokalaemia: Insights From Pre-clinical Models
por: Tse, Gary, et al.
Publicado: (2021)

Arrhythmic Risk Assessment of Hypokalaemia Using Human Pluripotent Stem Cell-Derived Cardiac Anisotropic Sheets
por: Gurung, Bimal, et al.
Publicado: (2021)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Anticoagulants/azithromycin/hydroxychloroquine: Spontaneous haematoma: case report
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Azithromycin/ceftriaxone/hydroxychloroquine: Acute urticaria: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: SDRIFE-like rash: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Lack of efficacy: 2 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine/methylprednisolone: Various toxicities: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Various toxicities: 4 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine/methylprednisolone: Various toxicities: case report
Publicado: (2021)

Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
por: Li, Chunfeng, et al.
Publicado: (2020)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice
por: Li, Ka Hou Christien, et al.
Publicado: (2017)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
por: Arshad, Samia, et al.
Publicado: (2020)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Amphotericin-b-liposomal/azithromycin/hydroxychloroquine: No response: case report
Publicado: (2021)

Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
por: Xu, Jiuyang, et al.
Publicado: (2022)

Azithromycin/hydroxychloroquine/oseltamivir: Erythema multiforme major: case report
Publicado: (2021)

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
por: EL Ouarradi, Amal, et al.
Publicado: (2020)

Azithromycin/favipiravir/hydroxychloroquine: Various toxicities: 7 case reports
Publicado: (2022)

Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection
por: Bajpai, Jyoti, et al.
Publicado: (2022)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o2j2huh7nglt53lfd23a5tpc84